Improving Health Outcomes With Kefir

Recruiting N/A Interventional Study
Systemic Inflammatory Response Diabetes Mellitus, Type 2 Cardiovascular Diseases
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
24 – 70
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
156 (estimated)
Sponsor
University of Alberta · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of the study is to ascertain whether traditional kefir not only enhances vascular health but also contributes to improved immune outcomes in both male and female participants at higher risk or living with Type 2 Diabetes (T2D) after 12 weeks of treatment.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. females and males (24-70 years old) living in Edmonton (or Edmonton area/driving distance); 2. overweight or obesity (BMI \>25 Caucasian, \>23 Asian); 3. at higher risk of T2D (fasting blood glucose ≥ 5.6 - 6.9 mmol/L or/and HbA1C ≥ 5.5 - 6.4%); or 4. with diagnosis of T2D (f…
Contacts

Paulina Aldana Hernandez, PhD

780-492-9506

paldana@ualberta.ca

CONTACT